The Future of Pharma: Evolutionary Threats and Opportunities

 

Description:

By any standard, the pharmaceutical industry's history has been a successful one.

In addition to its profits and shareholder dividends, it has been seen by investors as relatively low risk and, largely, counter-cyclical to stock market trends.

However, that important contribution appears to be petering out, with significant global implications for employees, shareholders, governments and patients.

This is not just caused by the economic crisis.

Long before this, several distinct but related streams of evidence emerged that now point to the stalling of the pharmaceutical industry.

The Future of Pharma examines the causes of the industry's potential decline and offers a convincing and rigorous analysis of the options open to it.

What emerges is a landscape defined, on the one hand, by the changing marketplace of mass-market consumers, institutional healthcare systems and wealthy individuals; and on the other by the alternate sources of commercial value - innovative therapies; super-efficient processes, supply chains and operations; and closer customer relations and increasingly tailored health services.

The challenges to the pharmaceutical industry now and in the medium and long-term are very significant.

Brian Smith's highly readable research findings are a wake-up call and a first step forward for anyone concerned with the future of the industry; whether executive, customer, policymaker or investor.

 

 

Table of Contents:

 

Part I A Stalling Industry

Chapter 1 Whither Pharma?

The World’s Most Important Industry at a Fork in the Road

Chapter 2 Universal Acid: A Way to Understand the Complex, Adaptive Pharmaceutical Industry

Part II A Co-Evolving Industry

Chapter 3 An Evolving Social Environment

Chapter 4 An Evolving Technological Environment

Chapter 5 The Evolution of the Pharmaceutical Industry

Chapter 6 The Speciation of Pharma: The New Business Models that Will Transform the Industry

Part III A Changed Industry

Chapter 7 Sex, Forced Moves and Good Tricks: What New Capabilities Will Be Needed to Survive and Thrive in the Future of Pharma?

Chapter 8 Flat, Focussed Tribes: Organizational Structures in the Future of Pharma

Chapter 9 Gales of Creative Destruction: The Turmoil Ahead of the Pharmaceutical Industry

Epilogue: Unanswered Questions and Speculative Answers

Appendix 1: A Pragmatic Research Approach

Appendix 2: List of Research Interviewees